Inspection trends continue to highlight weaknesses in pharmaceutical documentation hierarchy and procedural governance. This article analyzes how SOP hierarchy in pharma, work instruction in GMP, and GMP document control systems influence audit readiness, data integrity risk, and CAPA effectiveness.
